Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance

BACKGROUND: Extent of myocardial fibrosis (MF) determined using late gadolinium enhanced (LGE) predicts outcomes, but gadolinium is contraindicated in advanced renal disease. We assessed the ability of native T1-mapping to identify and quantify MF in aortic stenosis patients (AS) as a model for use...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cardiovasc Disord
Päätekijät: Graham-Brown, M. P., Singh, A. S., Gulsin, G. S., Levelt, E., Arnold, J. A., Stensel, D. J., Burton, J. O., McCann, G. P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6044074/
https://ncbi.nlm.nih.gov/pubmed/30005636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0885-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia